Evidence supporting the use of: Resveratrol conjugates (mixed)
For the body system: Hepatic System

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Resveratrol conjugates, including glucuronide and sulfate derivatives, are metabolites of resveratrol—a polyphenol found in grapes, berries, and peanuts. The hepatic system (liver) is the primary site for the metabolism and conjugation of resveratrol. Scientific studies, primarily in vitro and in animal models, have shown that resveratrol and its conjugates can exert hepatoprotective effects. Resveratrol has demonstrated the ability to reduce hepatic oxidative stress, inflammation, and fibrosis in models of liver injury, non-alcoholic fatty liver disease (NAFLD), and toxin-induced liver damage.

Conjugated forms are the predominant circulating metabolites in humans after oral ingestion, but their direct biological activity in the liver is less well-characterized compared to the parent compound. Some studies indicate that these conjugates can enter hepatocytes and may be deconjugated locally to release active resveratrol, thereby contributing to its protective effects. Moreover, resveratrol and its metabolites have shown potential to modulate liver enzymes involved in detoxification and to improve markers of liver function in preclinical studies.

Human clinical evidence is limited but suggests a favorable safety profile and some benefit in liver enzyme normalization. However, most of the evidence supporting the use of resveratrol conjugates for liver health is preclinical, and more research is needed to confirm efficacy in humans. Thus, while there is a scientific rationale and some supporting data, the strength of evidence is moderate.

More about Resveratrol conjugates (mixed)
More about Hepatic System

Products containing Resveratrol conjugates (mixed)

We currently have no products on Vitabase that contain this ingredient.